Position in AUPH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,654,729
+$2,441,495 QoQ
Shares Held
863,567
+4.8% QoQ
Ownership
0.649%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 279 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. AUPH ranks #95 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in AUPH
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,654,729 | 863,567 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $12,213,234 | 824,105 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $12,762,294 | 800,144 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $9,905,737 | 896,447 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $7,803,163 | 921,271 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $8,260,960 | 1,027,483 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,468,195 | 1,054,365 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $7,298,398 | 995,689 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $5,595,705 | 979,984 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $5,124,186 | 1,022,792 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $9,593,902 | 1,067,175 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,122,609 | 1,045,381 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,776,693 | 1,009,989 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,803,489 | 985,720 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,437,143 | 1,027,117 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,556,606 | 1,004,868 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,244,135 | 1,019,317 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,265,284 | 102,204 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,320,755 | 101,476 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,143,666 | 96,867 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||